Answers are grounded in this paper and cite their sources.
Divergent spectrum of the mechanisms of residual cardiovascular risk linked to JCAD that could be therapeutically targeted in the future.
No takes yet. Share an insight, caveat, or question.
Guzik et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: